Logo image
Bowel management post major joint arthroplasty: A randomised controlled trial to test two pre-admission bowel regimens
Journal article   Peer reviewed

Bowel management post major joint arthroplasty: A randomised controlled trial to test two pre-admission bowel regimens

G.M. Ross-Adjie, A.A. Cranfield, P.J. Yates and L. Monterosso
International Journal of Orthopaedic and Trauma Nursing, Vol.41, Art. 100816
2020
url
Link to Published Version *Subscription may be requiredView

Abstract

Background The length of stay for patients undergoing joint arthroplasty has reduced but there is a paucity of knowledge relating to bowel management within this enhanced recovery framework. Aim The study's primary aim was to determine which of two dosage regimens of macrogol (Movicol®) commenced pre-operatively is most effective in facilitating a return to normal bowel function. Procedure Ninety-one eligible patients were randomised to one of three groups: 1) commence macrogol one sachet in the morning for two days prior to surgery; 2) commence macrogol one sachet, morning and evening of the day prior to surgery; or 3) control group. Results Seventy-seven percent of patients in group one, and 83% of group two had returned to normal bowel function by one-week post discharge compared to 70% of control patients (p = .470). Participants in group one required less aperients in the week following discharge compared with the other two groups although the result was not statistically significant (p = .060). Conclusion Despite not reaching statistical significance, the results are considered clinically significant. The authors recommend patients commence macrogol one sachet in the morning for the two days prior to admission for major joint arthroplasty and the Murdoch Bowel Protocol® continue to be followed for inpatients.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

Logo image